Skip to content
10-Q

Quarterly Report

COLLEGIUM PHARMACEUTICAL, INC COLL

0001558370-25-010649

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 31.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.28M sh
Shares Diluted Q2 2025 · Jun 30, 2024 40.38M sh
Shares Diluted Q2 2025 · Jun 30, 2024 40.51M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $25.1M
Stock Repurchased Q2 2025 · Jun 30, 2024 $35M
Capex Q2 2025 · Jun 30, 2025 $863K
Capex Q2 2025 · Jun 30, 2024 $838K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $127.84M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $129.34M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $117.35M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $70.57M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $172.89M
Stockholders Equity Q2 2025 · Jun 30, 2025 $232.21M
Stockholders Equity Q2 2025 · Mar 31, 2025 $234.43M
Stockholders Equity Q2 2025 · Dec 31, 2024 $228.84M
Stockholders Equity Q2 2025 · Jun 30, 2024 $216.58M
Stockholders Equity Q2 2025 · Mar 31, 2024 $222.17M
Stockholders Equity Q2 2025 · Dec 31, 2023 $195.43M
Current Liabilities Q2 2025 · Jun 30, 2025 $464.61M
Current Liabilities Q2 2025 · Dec 31, 2024 $509.51M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.36B
Total Liabilities Q2 2025 · Dec 31, 2024 $1.43B
Current Assets Q2 2025 · Jun 30, 2025 $549.21M
Current Assets Q2 2025 · Dec 31, 2024 $482.26M
Total Assets Q2 2025 · Jun 30, 2025 $1.59B
Total Assets Q2 2025 · Dec 31, 2024 $1.66B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.34
Eps Diluted Q2 2025 · Jun 30, 2025 $0.44
Eps Diluted Q2 2025 · Jun 30, 2024 $0.52
Eps Diluted Q2 2025 · Jun 30, 2024 $1.24
Eps Basic Q2 2025 · Jun 30, 2025 $0.38
Eps Basic Q2 2025 · Jun 30, 2025 $0.45
Eps Basic Q2 2025 · Jun 30, 2024 $0.60
Eps Basic Q2 2025 · Jun 30, 2024 $1.46
Sga Expense Q2 2025 · Jun 30, 2025 $73.64M
Sga Expense Q2 2025 · Jun 30, 2025 $150.06M
Sga Expense Q2 2025 · Jun 30, 2024 $43.34M
Sga Expense Q2 2025 · Jun 30, 2024 $85.32M
Net Income Q2 2025 · Jun 30, 2025 $11.98M
Net Income Q2 2025 · Jun 30, 2025 $14.4M
Net Income Q2 2025 · Mar 31, 2025 $2.42M
Net Income Q2 2025 · Jun 30, 2024 $19.61M
Net Income Q2 2025 · Jun 30, 2024 $47.32M
Net Income Q2 2025 · Mar 31, 2024 $27.71M
Operating Income Q2 2025 · Jun 30, 2025 $35.11M
Operating Income Q2 2025 · Jun 30, 2025 $56.79M
Operating Income Q2 2025 · Jun 30, 2024 $47.47M
Operating Income Q2 2025 · Jun 30, 2024 $96.95M
Gross Profit Q2 2025 · Jun 30, 2025 $108.38M
Gross Profit Q2 2025 · Jun 30, 2025 $205.71M
Gross Profit Q2 2025 · Jun 30, 2024 $90.81M
Gross Profit Q2 2025 · Jun 30, 2024 $182.26M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $79.62M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $160.05M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $54.47M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $107.94M
Revenue Q2 2025 · Jun 30, 2025 $188M
Revenue Q2 2025 · Jun 30, 2025 $365.76M
Revenue Q2 2025 · Jun 30, 2024 $145.28M
Revenue Q2 2025 · Jun 30, 2024 $290.2M